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A B S T R A C T
Chronic occupational exposure to organophosphorus pesticides (OPs) is consistently associated with deﬁcits on
behavioral tests when compared to unexposed comparison groups. However, a dose-response relationship has
yet to be established, leading some to doubt an association between occupational OP exposure and behavioral
deﬁcits. Pesticide application teams in Egypt who are primarily exposed to one OP, chlorpyrifos (CPF), were
recruited into a ﬁeld assessment. Trail Making A and the more challenging Trail Making B tests were ad-
ministered to 54 engineers (who supervise the pesticide application process, usually from the side of the ﬁeld),
59 technicians (who guide the pesticide applicators in the ﬁeld), 31 applicators (who mix and apply pesticides
using knapsack sprayers), and 150 controls (who did not work in the ﬁelds) at two diﬀerent times during the OP
application season as well as immediately after applications had ended and 1.5 months later. All participants
were males since only males work on pesticide application teams in Egypt. Urinary levels of 3,5,6-trichloro-2-
pyridinol (TCPy), a speciﬁc metabolite of CPF, conﬁrmed the pattern of lower to higher CPF exposures from
engineers to technicians to applicators, and these were all greater than urinary metabolite levels in controls. A
consistent relationship between job title and performance speed on the behavioral task was observed: Controls
had the best (fastest) performance on Trail Making A and B tests throughout the application season, and ap-
plicators had signiﬁcantly slower performance than engineers on Trail Making A (p= 0.015) and B (p=0.003).
However, individual urinary TCPy, blood acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) levels
did not predict individual performance. This study identiﬁes a dose-related eﬀect based on job title, which serves
as a surrogate for chronic exposure in that diﬀering job titles exhibit varying group exposure levels. The results
establish that chronic occupational exposure to chlorpyrifos is neurotoxic and suggest that the classic biomarkers
of recent CPF exposure are not predictive of chronic exposure eﬀects.
1. Introduction
Human occupational exposures to organophosphorus pesticides
(OPs), including chlorpyrifos (CPF), have been studied extensively in
cross-sectional studies, and several meta-analyses or systematic ana-
lyses of these data have concluded that adverse behavioral eﬀects are
associated with occupational exposure to OP pesticides in adults (Ismail
et al., 2012; Meyer-Baron et al., 2015; Munoz-Quezada et al., 2016;
Rohlman et al., 2011; Ross et al., 2013) and developmental OP ex-
posures in children (Gonzalez-Alzaga et al., 2014; Jurewicz and Hanke,
2008). However, only a few studies in adults have reported an asso-
ciation between biomarkers of exposure and behavioral outcomes in
occupationally-exposed cohorts (e.g., Abdel Rasoul et al., 2008; Ismail
et al., 2017b; Rohlman et al., 2016; Rothlein et al., 2006). One study in
children (Rauh et al., 2011) identiﬁed declines in full scale IQ on the
Wechsler Intelligence Scale for Children (WISC) in 7-year-olds that
were correlated with individual CPF levels in umbilical blood plasma
that had been collected prenatally. The association between OP ex-
posures and behavioral deﬁcits in humans, and speciﬁcally adults, is
still questioned by some, in part because of the paucity of evidence of a
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correlation between the behavioral changes and biomarker(s) of ex-
posure (as noted by Meyer-Baron et al., 2015), and because a dose-
response relationship has yet to be demonstrated. Other reviews have
emphasized inconsistent ﬁndings and limited exposure assessments as
reasons for the continued uncertainty (Burns et al., 2013; Li et al.,
2012) as summarized by Rohlman et al. (2016). A signiﬁcant limitation
of these assessments is that each of the epidemiological studies com-
pared a single OP-exposed population to an unexposed or control po-
pulation.
Thus, there is a need to identify workers with a range of OP ex-
posures that allows an examination of the relationship between dif-
ferent occupational exposure levels and behavioral performance and to
test their relationship with biomarkers of exposure collected at the time
of testing: urinary 3,5,6-Trichloro-2-pyridinol (TCPy), a speciﬁc meta-
bolite of CPF, and blood acetylcholinesterase (AChE) and butyr-
ylcholinesterase (BuChE). All these are established biomarkers of recent
OP exposure (Alexander et al., 2006; Wang et al., 2016).
Pesticide application teams working for the Ministry of Agriculture
(MOA) in Egypt apply CPF and pyrethroids to the cotton crop (see
Fig. 1). The MOA regulates pesticide applications to the cotton crop by
supplying and maintaining the equipment; dictating the pesticides and
concentration levels to be applied, as well as the application schedule;
and monitoring the eﬀects on pest infestation of the cotton plants. The
pesticide application teams consist of applicators who mix, load and
apply the pesticides, technicians who support the applicators by
walking next to the applicators and directing their walking speed in
areas of heavier vs. lighter pest infestation, and engineers who oversee
the pesticide application process, including pesticide mixing and ap-
plications. CPF is the primary pesticide that is used in cotton production
in Egypt, and it is applied in a routine of daily applications for up to 4
weeks, followed by an application of a pyrethroid pesticide, then an
additional application cycle of CPF depending on the degree of in-
festation (T. M. Farahat et al., 2003; Rohlman et al., 2011). This cycle
has been followed for at least 15 years prior to the time of this study.
Adult engineers and technicians from the Egyptian MOA had been
studied previously, revealing a broad range of adverse behavioral test
deﬁcits relative to control performance (T. M. Farahat et al., 2003).
However, in that earlier study, comparisons were between exposed
workers and non-exposed controls, so it was not possible to delineate a
dose-response relationship.
The purpose of this study was to assess the impact of CPF exposures
on the Trail Making Test, a prototypical behavioral test of search,
scanning, processing speed, mental ﬂexibility and executive function
(Tombaugh, 2004) used in many prior studies examining OP eﬀects and
considered a valuable screening test for cognitive eﬀects of pesticides
(Lucero et al., 2019). The overall study was designed to assess cognitive
and motor speed performance of worker job categories with diﬀerent
exposure histories and to test our primary hypothesis that the me-
chanisms mediating the behavioral eﬀects of long-term or chronic
exposures are unrelated to the classic biomarkers of recent CPF ex-
posures. To address our primary hypothesis, we describe the results as a
series of tests of eight hypotheses: 1) Higher urinary TCPy concentra-
tions will be detected in applicators who walk directly into the pesticide
spray than in technicians who walk beside them or engineers who are
not often in the ﬁeld during applications; 2) The average activity of
blood cholinesterase, a biomarker of recent OP exposure, will be lower
in applicators than in technicians or engineers during periods of CPF
application; 3) Pesticide workers will demonstrate deﬁcits (slower
performance) on the Trail Making Test compared to controls, and job
titles with higher CPF exposures will have greater deﬁcits in perfor-
mance than those with lower CPF exposures; 4) A greater number of
years working for the MOA, and thus more years of exposure to CPF,
will be associated with greater deﬁcits on the Trail Making Test; 5) Peak
exposures deﬁned by urinary TCPy measures will be negatively asso-
ciated with post-exposure Trail Making performance; 6) Higher CPF
exposure concentrations (based on actual 2009 urinary TCPy con-
centrations) multiplied by years applying pesticides (i.e., cumulative
exposure) will be associated with greater deﬁcits in post-exposure Trail
Making Test performance; 7) Trail Making performance will correlate
in a dose-response fashion with urinary TCPy levels and both BChE and
AChE cholinesterase inhibition; and 8) Trail Making Test deﬁcits will
persist after CPF exposure ends.
2. Materials and methods
2.1. Overview
A ﬁeld study was conducted in 2009 and 2010 to examine the im-
pact of CPF exposure on behavioral performance in pesticide applica-
tion teams employed in Egyptian cotton ﬁelds for the Ministry of
Agriculture (MOA) and controls working for the MOA but not in the
ﬁelds.
2.2. Recruitment
The MOA in the Menouﬁa Governorate in Egypt’s Nile Delta pro-
vided access to the population that included members of pesticide ap-
plication teams (applicators, technicians and engineers) and controls
who had the same job titles as technicians and engineers but did not
work in the agricultural ﬁelds. A team typically consisted of 1 engineer,
1 technician and 3 applicators, although additional technicians or ap-
plicators were assigned to a team depending on availability and the size
of the ﬁeld to be sprayed on any given day. Control participants worked
in oﬃce jobs recording crop and pesticide application data and pre-
paring informational materials for the local farmers or performing other
job activities not related to pesticide application. Members of pesticide
application teams were recruited at the MOA oﬃces in the Menouﬁa
governorate or at ﬁeld stations operated by the MOA and tested in 2009
(the “2009 cohort”), with a subset retested in 2010 (the “2010 cohort”).
The controls were recruited and tested in 2010. The applicators, en-
gineers, technicians and controls were employed by the MOA year-
round. However, some applicators who worked at these stations were
adolescents who worked for the MOA only during the summer pesticide
application season. Some participants also reported applying pesticides
on family and neighbors’ farms (Lein et al., 2012; Rohlman et al.,
2016). Only males work in these job categories in Egypt. In addition, a
sample of 101 Menouﬁa University employees were recruited in 2009
to provide urine samples from Egyptians who did not work near the
cotton ﬁelds.
2.3. Study setting
Study activities were conducted by staﬀ in an open room with tables
arranged along the walls in MOA oﬃces in Menouﬁa Governorate.
Participants received compensation equivalent to a day’s pay for the
Fig. 1. Pesticide applicators wearing backpack sprayers and technicians
guiding the walking speed to increase or decrease pesticide concentration and
to focus the spray direction of the applicators in Egyptian cotton ﬁelds.
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lower-paid workers. The project was approved by the Ethics Committee
at Menouﬁa University and the IRB of Oregon Health & Science
University. All participants signed a consent form prior to data collec-
tion.
2.4. Application/exposure schedule/study design
Five test sessions were conducted during the two years of the study
that corresponded with speciﬁc time points within the application cycle
(Fig. 2). Annually, CPF was applied from July 1 until July 15, pyre-
throids were applied from mid-July to the end of July, and CPF was
again applied from approximately August 1 until August 10. The exact
dates on which applications occurred depended on the number of
cotton ﬁelds assigned to a particular ﬁeld station and the level of insect
infestation in the cotton crop in those ﬁelds. Thus, the initial round of
pesticide applications each summer began at some ﬁeld stations on July
1 while at others it started as late as July 5, and the applications con-
tinued until all the assigned ﬁelds were treated, by July 15. The pyre-
throid and second round of CPF applications followed the same pattern.
Each ﬁeld station director had control over the exact schedule of ap-
plication on their assigned farms in collaboration with the MOA di-
rectorate. However, the pesticides and the concentrations to be applied
were set by the MOA and these were constant from year to year.
Test session 1 was conducted prior to the beginning of pesticide
applications and represented baseline (although some applicators may
have applied pesticides on private farms during this time). Sessions 2
and 3 were conducted in mid-July and early August during the CPF
application. Session 4 was conducted shortly after CPF applications had
ended (2nd to 3rd week of August, started one week earlier in 2010 than
in 2009 because of the start of Ramadan), and Session 5 was in late
September or early October, shortly after Ramadan had ended (several
weeks after applications had concluded). Application team participants
applied pesticides daily during the afternoons. All testing sessions were
conducted in the morning when there were no pesticide applications.
At the start of each workday, technicians collected approximately
100 cotton bolls from diﬀerent locations in each ﬁeld scheduled to be
sprayed that day to determine the number of weevils per boll in each
ﬁeld. This determination in turn led to adjustments in the pace walked
by the applicators. The pesticide was applied at a standard walking pace
using mist-blowers to apply 80 Liters of Pestban (CPF) to a feddan
(0.42 ha, or 1.04 acres) in 20min. This was designed to produce an
application rate of 0.02 liters of diluted CPF per square meter (F. M.
Farahat et al., 2011; Singleton et al., 2015, 2014). In areas of heavier
infestation, technicians would direct applicators to walk more slowly in
order to increase the concentration in those areas (the technicians are
seen walking ahead and to the side of the applicators in Fig. 1). En-
gineers who oversaw the process typically observed from the side of the
ﬁeld where mixing/loading of the backpack sprayers occurred, al-
though some would stand with the technicians and applicators during
spraying in the ﬁeld. Depending on the individual and the ﬁeld station
directives or traditions, the engineers may have participated in mixing/
loading and/or walked in the ﬁelds near the applicators (which we
observed in some instances).
2.5. Behavioral test
The Trail Making Test, parts A and B (US Army Individual Test
Battery developed in 1944 (M. Lezak et al., 2004) was administered in
Years 1 and 2 using the same protocol described in the prior study of
this same population (T. M. Farahat et al., 2003) but to diﬀerent people
at diﬀerent ﬁeld stations. Non-standard instructions were used in Ses-
sion 1 (2009) (viz., the instruction “try not to lift the pen as you move
from one number or letter to the next” was not clear and participants
were observed to lift the pen during testing), but this was corrected in
sessions 2–5; the Year 1 data from Session 1 were discarded. The Trail
Making Test measures complex visual scanning with a motor compo-
nent. It assesses rapid visual search, visuospatial sequencing and cog-
nitive set shifting; these are factors related to attention. Motor speed
and agility contribute strongly to test performance. Performance on the
test is particularly aﬀected by brain injury, such as head trauma (M. D.
Lezak, 1995).
Other behavioral tests were also administered, but they are not in-
cluded here. Time to complete the Trail Making Test is the primary
outcome measure. As this is a timed test, faster times reﬂect better
performance. Errors were relatively infrequent, but not described here.
2.6. Urinary 3,5,6-trichloro-2-pyridinol (TCPy)
Urine samples were collected at the same time as behavioral testing
(see Fig. 2) to analyze for 3,5,6-trichloro-2-pyridinol (TCPy), a CPF-
speciﬁc metabolite excreted in the urine (Fenske et al., 2012). Once
collected, urine samples were placed on wet ice in a cooler and trans-
ported to Menouﬁa University (Shebin El-Kom, Egypt), approximately
20min from the study ﬁeld stations, where they were stored at −20 °C.
Urine samples were shipped on dry ice and analyzed for TCPy at the
University at Buﬀalo (Buﬀalo, NY, USA) by negative-ion chemical io-
nization gas chromatography–mass spectrometry, using 13C-15N-
3,5,6TCPy as an internal standard (described previously by F. M.
Farahat et al., 2011; T. M. Farahat et al., 2003). Creatinine con-
centrations were measured using the Jaﬀe reaction (Fabiny and Er-
tingshausen 1971). Urine TCPy concentrations are expressed as mi-
crograms TCPy per gram creatinine.
Fig. 2. Schedule (days of month listed above the month) of pesticide application, test administration and sample collection in 2009.
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2.7. Quantiﬁcation of cholinesterase activity in the blood
Blood samples were collected at the same time as behavioral testing
was conducted to analyze for acetylcholinesterase (AChE) and butyr-
ylcholinesterase (BuChE), which are biomarkers of both exposure and
eﬀect (Rohlman et al., 2011). To establish the baseline ChE activity for
each worker, a single pre-exposure blood sample was collected in June
2009 prior to the start of the MOA-regulated CPF application season
(Session 1 in Fig. 2). Two additional blood samples were collected
during the period of CPF applications (during behavioral testing ses-
sions), and two post-CPF exposure blood samples were collected after
CPF spraying had ended.
Blood samples were collected by venipuncture into 10mL lavender
top (EDTA) vacutainer tubes and immediately placed on wet ice in a
cooler and transported to Menouﬁa University, where they were ana-
lyzed in triplicate for AChE and BuChE activity using an EQM Test-Mate
kit (EQM Research Inc., Cincinnati, OH, USA). The EQM Test-Mate kit is
a portable spectrophotometric analyzer developed for the determina-
tion of ChE activity in whole blood, based on the original Ellman
method (McConnell et al., 1992). The intraclass correlation coeﬃcient
for BuChE with this method is 0.987 and for AChE is 0.898, indicating
that there is very little variation among replicates relative to total
variation.
2.8. Statistical analysis methods
Estimating equations (GEE) were used to model and test for diﬀer-
ences in key responses of interest over multiple testing sessions while
controlling for potential demographic and occupational characteristics.
Speciﬁc analyses are described in each Results section.
3. Results
In Year 1 (2009) 144 members of pesticide application teams—31
applicators, 59 technicians, and 54 engineers—were recruited and
tested in ﬁve sessions (Fig. 2). A subset of 4 applicators, 19 technicians,
and 21 engineers was retested in 2010 (Year 2). Also in 2010, 150
subjects were recruited to serve as controls. Demographic character-
istics of these groups are summarized in Table 1.
3.1. Association of urinary TCPy concentration with job title
Among the 144 participants from the 2009 cohort, 142 (30 appli-
cators, 58 technicians, 54 engineers) had measurable concentrations of
urinary TCPy (ng/mg creatinine) in at least one of the ﬁve sessions
during which urine samples were collected. Urinary TCPy concentra-
tion was log-transformed prior to the GEE analysis to improve sym-
metry, stabilize variance, and lessen the inﬂuence of outliers in the test
of hypothesis 1.
The geometric mean (GM) concentration of urinary TCPy for en-
gineers did not diﬀer signiﬁcantly (p= 0.43) from the GM concentra-
tion in technicians for any session, while the GM concentration for
applicators was signiﬁcantly higher than both engineers (p= 0.018)
and technicians (p= 0.013) during Sessions 1-4. For Session 5, during
which urine samples were collected in September (approximately 6
weeks after applications ended), there were no diﬀerences between the
job type groups (p>0.30 for each comparison) (Fig. 3). Urinary TCPy
measures were not available for the 2010 cohort. The sample of 101
Menouﬁa University employees who did not work near the cotton
ﬁelds, recruited in 2009, provided urine samples on June 28 and August
12–13 (corresponding respectively to the testing time of Session 1 and 4
in the 2009 ﬁeld sample collection). The GM concentration of urinary
TCPy from these two time points were 5.5 (95 % CI=4.8–6.3) and 6.3
(95 % CI=6.4–8.7) ng/mg creatinine; the diﬀerence between the time
points was signiﬁcant (p=0.004). Even the high end of the CI for the
control values is lower than the GM of urinary TCPy for applicators on
all sessions except Session 1, whereas the GM of the University group is
close to the levels seen in the technicians and engineers.
These data support Hypothesis 1: Higher urinary TCPy concentra-
tions will be detected in applicators who walk directly into the pesticide
spray than in technicians who walk beside them or engineers who are
not often in the ﬁeld during applications. Based on the urinary TCPy
measures in 2009, there are essentially two exposure groups: applica-
tors and technicians+ engineers.
3.2. Association of blood cholinesterase activity with job title
AChE activity (U/gram of hemoglobin [gHgb]) and BuChE (U/mL)
was quantiﬁed for 139 (31 applicators, 54 engineers, 54 technicians) of
the 144 workers from Year 1 (2009) at Session 1 (pre-application),
Session 3 (during [the second period of] application), and Session 5
(post application); Session 3 was judged to be more representative of a
chlorpyrifos application period than Session 2. Blood cholinesterase
activity was measured in Year 2 (2010) for the 150 controls, but for
only a few applicators and none of the engineers or technicians.
Hypothesis 2, which focused on cholinesterase activity (AChE, BuChE)
was also analyzed using GEE following log-transformation of these
data. GEE models applied to these transformed outcomes estimate be-
havior of the geometric mean (GM) after transformation back to the
original scale with additive changes estimated on the log scale be-
coming multiplicative eﬀects (i.e., fold changes) concerning the GM
when back transformed.
Occupation/job title did not signiﬁcantly aﬀect the GM of AChE
Table 1
Mean years of age, education, and experience within MOA for study partici-
pants from 2009 and 2010, by job title; standard deviation (SD) given in par-
entheses.
Cohort Age Education MOA
2009
Applicator (n=31) 39.2 (13.3) 11.2 (2.5) 12.5 (9.3)
Engineer (n=54) 54.1 (4.1) 14.4 (3.0) 18.2 (8.6)
Technician (n=59) 48.0 (4.9) 12.3 (1.9) a 14.8 (9.2)
2010 (subset of above for applicators, engineers, and technicians)
Control (n=150) 49.6 (6.0) 13.0 (2.4) b 20.1 (9.4) c
Applicator (n=4) 40.7 (7.5) 12.0 (0.0) 16.5 (5.1)
Engineer (n=21) 54.0 (4.0) 13.5 (2.1) 17.3 (9.2)
Technician (n=19) 49.2 (3.8) 12.4 (1.2) 16.0 (9.7)
a 1 missing, n=58.
b 10 missing, n= 140.
c 3 missing, n=147.
Fig. 3. Geometric mean TCPy concentration (vertical axis; 95 % conﬁdence
interval as error bars) by job title and session during Year 1 (2009). Pesticide
applications began a few days before Session 2 and ended a few days before
Session 4.
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activity over time (p=0.43; test of occupation× session interaction),
implying all three occupations shared a similar AChE proﬁle over time.
The GM of AChE activity for all three job titles decreased steadily over
the pesticide application period compared to pre-application levels.
Pre-application GM activity was 28.4 (95 % CI: 27.8–28.9) U/gHgb,
and decreased 2.7 % (95 % CI: 1.9–3.4 %; p< 0.001) at each successive
session (e.g., 2.7 % decrease at Session 3, followed by a further 2.7 %
decrease from Session 3–5). The ﬁnal concentration post-application
(Session 5) was 94.7 % (95 % CI:93.2–96.2 %) of the initial pre-ap-
plication level (Fig. 4, A). The sample of controls (2010) had an esti-
mated GM AChE activity of 27.5 (95 % CI:27—28) U/gHgb over a
period spanning Sessions 1—3.
BuChE activity for the same cohort exhibited a somewhat diﬀerent
pattern. Pre-application GM activity of BuChE was similar (p=0.47)
for all occupations, estimated to be 1.73 (95 % CI: 1.64–1.81) U/ml
overall. Post-application activity levels also did not signiﬁcantly diﬀer
(p=0.41) among groups, though the GM activity post-application for
all groups was 8.7 % (95 % CI: 6.0–11.3 %; p< 0.001) less than
baseline. During Session 3 (application period), applicators had a GM
activity decrease of 22 % (95 % CI: 11.4–31.4 %; p<0.001) from
baseline, which was 14.6 % (95 % CI: 2.7–25.0 %; p=0.017) less than
ﬁnal post-application levels (in Session 5). For comparison, the sample
of 150 controls (2010) had BuChE activity that remained relatively
constant [X2(2df)= 3.77, p=0.15; test for change over time] for
Sessions 1–3, with a GM of 1.88 (95 % CI: 1.81–1.94) U/ml. All three
job title groups had consistently lower levels of BuChE activity during
2009 than even the lower conﬁdence limit for these controls (Fig. 4B).
These data partially support Hypothesis 2: The average activity of
blood cholinesterase, a biomarker of recent OP exposure, will be lower
in applicators than in technicians or engineers during periods of CPF
application, was supported for BuChE, but not for AChE.
3.3. Association of job title with trail making performance
Of 144 pesticide team members recruited in Year 1 (2009) and
described in Table 1, 139 (30 applicators, 58 technicians, 51 engineers)
completed both Trail Making tests A and B at Sessions 2-5. Trail Making
performance (A and B; Hypotheses 3, 4, 6, 7) over repeat testing ses-
sions did not require any transformation prior to analysis by GEE. All
GEE models presumed the (transformed) response followed an ap-
proximately normal distribution with exchangeable correlation struc-
ture of repeated measures taken over multiple testing sessions. Robust
standard errors were used to guard against potential misspeciﬁcation of
the actual correlation structure.
For both Trail Making A and B, increasing age was signiﬁcantly
(p< 0.005) associated with slower performance; each additional
decade of age was associated with an approximate 13 s increase in time
to complete the test. After controlling for age, there was no indication
that performance over time, compared to performance at Session 2, was
modiﬁed by occupation for either Trail Making A [X 2 (6 df)= 4.62,
p=0.59] or B [X 2 (6df)= 4.67, p=0.57; test of time×occupation
interaction], thereby implying all three occupations shared parallel
performance proﬁles over time. That is, across all job titles, and in
controls, performance got faster with each successive session and
slower with increased age of the participants.
Among those of similar age, and regardless of session, applicators
completed the Trail Making A test an average of 19.7 (95 % CI:
3.8–35.6; p= 0.015) s slower than engineers and 12.7 (95 % CI:
1.1–24.4; p= 0.032) s slower than technicians. Technicians averaged
7 s slower than engineers, which was an insigniﬁcant (p=0.28) dif-
ference. Performance at Sessions 3, 4, and 5 was, respectively, 35.7 (95
% CI: 22.6–48.8), 41.9 (95 % CI: 29.0–54.8), and 32.3 (95 % CI:
14.8–49.8) s faster than at Session 2 (p< 0.001 for each). Compared to
controls from 2010, applicators were slower at all sessions (p< 0.001
for each comparison) and technicians were also slower at each of the
same four sessions (p<0.04 for each); engineers only showed slower
performance (p< 0.001) than controls at Session 2 but not at any later
sessions (p>0.15 for Session 3–5) (Fig. 5, left).
For Trail Making B, controls had faster performance (p<0.001) at
each session when compared to all other occupations, with only per-
formance at Session 3 being signiﬁcantly diﬀerent from the other
Fig. 4. GM of AChE (A) and BuChE (B) activity for applicators, engineers and
technicians. The shaded bar represents 95 % conﬁdence band for AChE and
BuChE levels in controls from 2010.
Fig. 5. Performance (time to complete) of pesticide applicators and control subjects on Trail Making A (left) and B (right).
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sessions (approximately 18 s slower, p< 0.001). Adjusted for age, en-
gineers were 30 (95 % CI: 6.5–53; p= 0.012) s faster than applicators
and 26 (95 % CI: 9–44; p=0.003) s faster than technicians at each of
the testing sessions. Performance for applicators and technicians did not
signiﬁcantly diﬀer (p=0.75). As was the case for Trail Making A,
performance at Session 4 was fastest, being 45 s better than at Session 2
(95 % CI: 31–60 s; p< 0.001). Sessions 3 and 5 also had faster times
than Session 2, by 16 and 37 s, respectively (p≤ 0.05 for each) (Fig. 5,
right).
These data support Hypothesis 3: Pesticide workers will demon-
strate deﬁcits (slower performance) on the Trail Making Test compared
to controls, and job titles with higher exposures will have greater def-
icits in performance than those with lower exposures. These data also
support Hypothesis 8: Trail Making Test deﬁcits will persist after ex-
posure ends. Hypothesis 8 is the subject of a more extensive analysis
later in the Results (3.8).
3.4. Association of years working for the MOA with trail making
performance
The hypothesis that an increased number of years of occupational
CPF exposures is associated with greater deﬁcits in Trail Making per-
formance was tested by examining data from 2009 for the same subjects
described in section 3.3 using GEE analyses that presumed the (trans-
formed) response followed an approximately normal distribution with
exchangeable correlation structure of repeated measures taken over
multiple testing sessions. Robust standard errors were used to guard
against potential misspeciﬁcation of the actual correlation structure.
Both years of work at the MOA (and thus exposure) and education are
addressed. For both Trail Making A and B, after adjusting for age and
occupation, neither years of work for the MOA nor years of education
were signiﬁcantly associated with performance (Trail Making A:
p=0.60 for years of education, p=0.91 for years of work for MOA;
Trail Making B: p=0.70 for years of education, p= 0.25 for years of
work for MOA). Each 5 years of experience working for the MOA was
associated with a 0.2-s increase in Trail Making A performance, em-
phasizing the lack of impact of years working for the MOA on test
performance.
These data do not support Hypothesis 4: A greater number of years
working for the MOA, and thus more years of exposure to CPF, will be
associated with greater deﬁcits on the Trail Making Test.
3.5. Association of peak urinary TCPy levels with post-exposure trail
making performance
We examined whether performance was associated with an in-
dividual's peak urinary TCPy concentration observed over Sessions 1–5,
to test whether this peak concentration was associated with average
performance from Sessions 4 and 5, after exposure had ended. We
thought peak exposure might be a better predictor of persistent eﬀects
than average exposure. Trail Making performance was tested using
ordinary multivariable regression with robust standard errors.
Of the 144 subjects from 2009, 142 (30 applicators, 58 technicians,
54 engineers) had at least one urine sample collected for TCPy quan-
tiﬁcation during the ﬁve sessions from which a maximal or peak value
could be obtained. Session 2 was most frequently associated with the
highest urinary TCPy level, regardless of job title. The sample size de-
creases to 124 when peak urinary TCPy concentration is correlated with
average performance from those participants who completed beha-
vioral testing during Sessions 4 and 5, and these are the same subjects
described in Section 3.6 and Table 2. Over the entire sample, the
median and inter-quartile range (IQR) for peak TCPy concentration was
22.3 [13.0–46.2] ng/mg creatinine with a marginally signiﬁcant
(p=0.05) diﬀerence among the three occupations. The median [IQR]
peak was 38.8 ([15.6–102.4] for applicators, 21.7 [12.8–34.0] for
technicians and 21.2 [11.8–40.2] for engineers.
There was some evidence to suggest that peak urinary TCPy con-
centration had a diﬀerential eﬀect on Trail Making A performance ac-
cording to job title (p=0.09; test of TCPy× occupation interaction).
After adjusting for age, the approximate 3.55-fold increase in TCPy
from 13 to 46.2 ng/mg creatinine is associated with a 7.7 s decrease in
completion time for applicators (p=0.08), a 25.6 s increase in com-
pletion time for engineers (p=0.19), and a 1.8 s increase in completion
time for technicians (p=0.59). This analysis also relied on GEE models
and was expanded to contain all collected measures of CPF exposure
(TCPy, AChE, BuChE) to explore their inﬂuence after controlling for
other known demographic/occupational factors.
For Trail Making B, there was no indication that the eﬀect of peak
TCPy concentration was modiﬁed by occupation (p= 0.57; test of
TCPy× occupation interaction), implying a similar trend for all occu-
pations, after adjusting for age. This trend was associated with an in-
creased completion time (i.e., worse performance) of approximately
10.6 (95 % CI: 1.1–20.2; p= 0.03) s over the central half-sample from
13 to 46.2 ng/mg creatinine. By comparison, this eﬀect is only slightly
smaller than the estimated eﬀect associated with a 10 year increase in
age, which was estimated to be a 12.3 (95 % CI: 2.4–22.1) s increase in
time needed to complete Trail Making B. Even after adjusting for peak
TCPy and age, there still remain persistent eﬀects due to job, with ap-
plicators and technicians respectively taking an average of 26.6
(p= 0.06) and 24.4 (p=0.005) s longer to ﬁnish than engineers.
Thus, Hypothesis 5: Peak exposures deﬁned by TCPy measures will
be negatively associated with post-exposure Trail Making performance,
was not supported by the data.
3.6. Association of estimated cumulative exposures with post-exposure trail
making performance
As employees have the same job and job title from year to year,
years of work in the MOA served as the basis for deﬁning cumulative
exposure. The concept for this analysis was predicated on the as-
sumption that TCPy exposure during the application periods (Sessions 2
and 3) in 2009 was reﬂective of a person's typical exposure experience
in all years they worked for the MOA (i.e., a person who carefully
Table 2
Descriptive characteristics for 124 participants used to determine associations
between post-exposure performance (Sessions 4 and 5) and demographic
characteristics or measures of exposure from earlier Sessions (2 and 3) when
CPF application was ongoing.
Applicator Technician Engineer
Characteristic (n= 30) (n= 47) (n= 47) p-value
Trails A, s
mean (SD) 83.2 (31.8) 76.7 (16.9) 78.7 (50.3) 0.60
Trails B, s
mean (SD) 168.1 (52.2) 171.4 (36.8) 152.9 (44.0) 0.09
Age, yrs
mean (SD) 38.9 (13.5) 48.7 (4.6) 54.1 (4.3) <0.001
Education, yrs
mean (SD) 11.0 (2.3) 12.3 (1.2) 14.5 (3.0) <0.001
Years MOA
mean (SD) 12.9 (9.2) 14.7 (9.4) 18.5 (8.3) 0.02
GMa TCPy, ng/mg
creat.
median [IQR] 20.8
[11.8–50.3]
12.5
[7.8–20.2]
12.1
[8.9–20.6]
0.03
Relativeb AChE
median [IQR] 0.98
[0.93–1.01]
0.98
[0.95–1.01]
0.97
[0.94–1.00]
0.63
Relativeb BuChE
median [IQR] 0.86 [0.68-
0.94]
0.94
[0.86–1.00]
0.94 [0.90-
0.99]
0.01
a Geometric mean from Session 2 & 3.
b Geometric mean activity from Session 2 & 3, divided by activity at Session
1.
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avoided skin exposure to pesticides during 2009 would have behaved
similarly over their working lifetime, and those who, for example,
stirred the pesticide mixture with their hands in 2009 would have done
so over the years; these hypothetical application team members would
have vastly diﬀerent skin exposures). Thus, years working in the MOA
was multiplied by their GM urinary TCPy concentration from the two
application periods (Sessions 2 and 3 in 2009) to estimate each person's
cumulative exposure over their lifetime of working. This measure has
units of ng TCPy*year/mg creatinine and was square-root transformed
prior to analysis to improve symmetry. This transformation preserves
order, so the ranking of individuals on the transformed scale is identical
to that on the original scale. For this analysis, we created an additional
explanatory variable deﬁned as the product between the application-
speciﬁc (Sessions 2 & 3) GM TCPy concentration and years working for
the MOA. GEE models of the sort previously described were then ﬁt to
Trail Making A / B performance over time while including this new
composite predictor in addition to other demographic and occupational
explanatory variables. Again, the models presumed the (transformed)
response followed an approximately normal distribution with ex-
changeable correlation structure of repeated measures taken over
multiple testing sessions. Robust standard errors were used to guard
against potential misspeciﬁcation of the actual correlation structure.
Fig. 6 shows the distribution of this cumulative exposure measure
among the three job titles for a sample of 137 subjects. These are the
same subjects examined in Section 3.3, but missing two applicators for
whom there was no TCPy measures during the two sessions in question.
The same models described in Section 3.3 (examining age and occu-
pation) were used here as well, but with inclusion of the (transformed)
cumulative exposure measure as well as an interaction between this
cumulative exposure measure and session. Thus, the cumulative mea-
sure of exposure for each person derived from Sessions 2–3, was used as
a predictor for performance at all sessions. This interaction was used to
assess whether any trend associated with cumulative exposure ﬂuc-
tuates according to session. However, no diﬀerence was noted among
job titles.
Transformed cumulative exposure was not associated with job title
(p=0.38), and overall had a median of 15 units (IQR from 9 to 20
units). Adjusted for job title and age, we found a signiﬁcant (p= 0.05)
interaction between cumulative exposure and session in relation to
performance on Trail Making A, but not for Trail Making B (p= 0.67).
The interpretation of the interaction was made by considering the ob-
served IQR for the exposure and reporting the change in the average
performance on Trail Making A over this range from 9 to 20 units (i.e.,
change in performance over the central half-sample of transformed
cumulative exposure) at Sessions 2—5.
The eﬀect associated with cumulative exposure alternates between
(insigniﬁcant) increases and decreases in performance, with the trend
for an 11 unit gain in cumulative exposure varying from just under a 3 s
worsening in performance to a little more than a 2 s improvement.
These measured eﬀects related to cumulative exposure, however, are
considerably smaller than the 13.2 (95 % CI: 8.3–18; p<0.001) s in-
crease in completion time per 10-year increase in age, and they are thus
far less important than age.
These data do not support hypothesis 6: Higher CPF exposure con-
centrations (based on actual 2009 TCPy exposures) multiplied by years
applying pesticides (i.e., cumulative exposure) will be associated with
greater deﬁcits in post-exposure Trail Making Test performance.
3.7. Association of TCPy, BuChE, and AChE with trail making performance
We tested whether Trail Making performance correlates with es-
tablished biomarkers of CPF exposure (i.e, blood AChE, blood BuChE,
and urinary TCPy) in a dose-response manner. The analysis used the
same GEE models described in the methods, with Trail Making per-
formance as the response and percent cholinesterase inhibition (or log-
TCPy concentration), occupation, session, and age as explanatory
characteristics. The analyses for hypothesis 7 also relied on GEE models
and were expanded to contain all collected measures of CPF exposure
(TCPy, AChE, BuChE) to explore their inﬂuence after controlling for
other known demographic/occupational factors. Cholinesterase in-
hibition was determined by dividing each participant's BuChE and
AChE activity at Session 2, 3, and 5 by his activity at Session 1. Session
4 was excluded because no participant had cholinesterase activity
measured during that session.
Of 144 participants described in Table 1, 132 (30 applicators, 51
technicians, 51 engineers) had blood BuChE and AChE activity re-
corded for Sessions 2, 3 and 5, and 138 (30 applicators, 57 technicians,
51 engineers) also had urinary TCPy recorded for Sessions 2, 3 and 5
[not every applicator provided a viable sample at each time point].
Mean years of age, education, and work experience for this slightly
smaller cohort was not diﬀerent from values given in Table 1 (diﬀer-
ences were always less than 0.4 years).
Controlling for age, occupation, and session, we found no associa-
tion between percent BuChE inhibition and performance on Trail
Making A (p= 0.24) or B (p= 0.65). For AChE, each 10 percentage
point increase in inhibition was associated with a marginally signiﬁcant
(p= 0.073) 1.5 s increase in Trail Making A completion time and a 2.4 s
decrease (95 % CI: 0.2–4.4; p= 0.029) in Trail Making B completion
time (Fig. 7). To be suggestive of an eﬀect, the direction of change
would be expected to be in the same direction for Trail Making A and B,
but it was not.
Individual urinary TCPy concentration was not associated with
contemporaneous participant performance on either Trail Making A
(p= 0.95) or B (p=0.83).
Thus, the data do not support Hypothesis 7: Trail Making Test
performance will correlate in a dose-response fashion with the urinary
TCPy biomarker and both BuChE and AChE biomarkers.
3.8. Persistence in trail making performance eﬀects after exposures had
ended
Data from Session 4 (7–10 days after CPF applications and occu-
pational exposures ended) and Session 5 (∼1.5 months post exposure
Fig. 6. Distribution of cumulative exposure of TCPy (GM from Sessions 2 and 3)
multiplied by years spent working for MOA (vertical axis; square-root scale).
For each job title, the white circle is the mean and the open circles represent
outliers. The black horizontal line in the center of each shaded area represents
the median. The v-shaped notches formed by the shaded areas denote the 95 %
CI for the median. The lower and upper edges of the shaded area represent the
25th and 75th percentiles. The whiskers extend to the largest and smallest non-
extreme values (within 1.5 box links).
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in the cotton ﬁelds) were examined to test whether Trail Making A or B
performance at these speciﬁc post-exposure periods was associated with
job title or biomarkers of exposure/eﬀect (urinary TCPy, blood AChE,
blood BuChE) measured during Sessions 2 and 3 (mid-July, early
August) when pesticide application teams were applying CPF. Prior
analyses (Section 3.3) revealed no signiﬁcant diﬀerences between Ses-
sion 4 and 5 for any occupation with respect to Trail Making perfor-
mance, after accounting for age (p= 0.11, Trails A; p=0.22 Trails B).
We subsequently averaged each participant's performance from these
two sessions and tested this average post-exposure performance mea-
sure for association with job title and three averaged measures of ex-
posure from Session 2 and 3. The GM TCPy concentration from those
two periods during CPF application and GM AChE and BuChE activity
from those same sessions relative to activity at Session 1 were calcu-
lated to generate a percent inhibition of cholinesterase activity. Al-
though the prior analyses found a strong eﬀect due to age, but no eﬀects
due to education or years working at the MOA, we included these
variables in this new analysis since it relies on a speciﬁc subset of
testing sessions and involves a more limited cohort of individuals. Since
this analysis involves summary measures of performance and exposure
computed at the level of the individual subject (i.e., no longer any
longitudinal component), ordinary multivariable regression was used to
estimate and test the associations of interest, with models using robust
standard errors to accommodate heteroscedasticity. Multivariable re-
gression was used to model average post-exposure Trail Making per-
formance (A / B; Sessions 4 and 5) as a function of average CPF ex-
posure measures (TCPy, AChE, BuChE) from active application periods
(Session 2 and 3) while controlling for other demographic/occupational
factors.
Table 2 gives descriptive characteristics for the 124 subjects (30
Applicators, 47 Technicians, 47 Engineers) who met the criterion of
having all the data used to address the hypothesis that post-exposure
performance varies by job title and exposures. We considered several
models in the process: Model 1 includes occupation and age (already
known to be non-negligible) without adjustment for other factors;
Model 2 expands Model 1 by also including years of education and
years of work for MOA; Model 3 expands Model 2 by also including all
exposure characteristics. These nested models allow for testing of dif-
ferences among job titles with varying degrees of adjustment, and also
determine whether inclusion of demographic or exposure character-
istics signiﬁcantly aﬀects performance. The Bayesian Information Cri-
terion [BIC], which quantiﬁes the balance between model accuracy and
parsimony/complexity, was computed (lower values preferred) to help
determine when additional terms were irrelevant (Schwarz, 1978).
Without controlling for any other factors, post-exposure perfor-
mance on Trail Making A does not diﬀer signiﬁcantly by job title
(p= 0.60), while post-exposure performance on Trail Making B has
some suggestive but inconclusive evidence of an eﬀect due to job title
(p= 0.09). All demographic characteristics show robust diﬀerences
among job titles (p≤0.02 for each), while exposure diﬀerences appear,
at least in an unadjusted sense, limited to urinary TCPy (p= 0.03) and
blood BuChE inhibition (p=0.01). These last conclusions regarding
exposure are similar to outcomes reported in Section 3.3 for the larger
cohort of 139 or 144 participants.
By contrast, regression models for Trail Making A that accounted for
age found applicators to be almost 20 s slower than engineers
(p= 0.06) and just over 15 s slower than technicians (p=0.05), with
no real diﬀerence between engineers and technicians (less than 4 s of
separation; p= 0.64). Each decade of age was associated with an
average increase of 10 additional s to complete the task. Further at-
tempts to include education, years working at the MOA, and the three
measures of exposure found those ﬁve variables didn't have a sig-
niﬁcant impact [F(5,115)= 1.12, p=0.35] beyond the initial model,
and more speciﬁcally, the exposures had no additional inﬂuence [F
(3,115)= 0.60, p=0.62] beyond a model that fully-adjusted for all
demographic characteristics. The comparative size and direction of
diﬀerences between job titles diﬀers by almost 1.5 s between the crude
(Model 1) and fully-adjusted model, suggesting the other demographic
and exposure variables are not strong confounders with performance on
Trail Making A. These results are summarized in Table 3.
Similar models for Trail Making B found age-adjusted performance
was best for engineers, who were on average 33 (p=0.02) and 25
(p= 0.01) s faster than applicators and technicians, respectively. Each
additional decade of age was associated with an approximate 12-s in-
crease in completion time. Although additional demographic and ex-
posure-related variables were not signiﬁcant [F(5,115)= 0.62,
p=0.68], they are confounded with occupation and performance such
that controlling for these ﬁve variables closes the performance gap
between applicators and engineers by nearly 13 s while the perfor-
mance gap between Engineers and Technicians is narrowed by 7 s.
Table 4 summarizes these ﬁndings for Trail Making B.
In sum, the diﬀerences in job title, which are associated with dif-
ferent exposure levels to CPF (section 3.3), diﬀer at Sessions 4 and 5
(when exposures had ended) once age diﬀerences are taken into ac-
count in the analysis. Fig. 5 also depicts the diﬀerences between the job
title groups, with a slightly larger N (because that analysis did not in-
clude all the variables and thus all the measures used in these more
comprehensive models). Taking all other relevant variables (viz., edu-
cation, years at the MOA, TCPy, AChE, BuChE) into account in the
analysis, which was not done in the prior sections, does not add any-
thing to the outcome of the analysis. Comparisons of model 2 vs. model
1 (p=0.35), model 3 vs. model 2 (p= 0.96), or model 3 with model 1
(p= 0.68) are not signiﬁcant and therefore do not improve on the
explanatory power of model 1. As the analysis controls for more and
more variables, the adjustments had little eﬀect. In the M3 vs. M1
comparison, there is no real diﬀerence in the model performance (i.e.,
the lowest BIC is M1 and there is little diﬀerence in that added com-
plexity without any added beneﬁt). That is, the more comprehensive
models don’t improve the explanatory power of the model – the added
variables just don’t matter.
Hypothesis 8. Trail Making Test deﬁcits will persist after exposure
ends, is conﬁrmed.
3.9. Trail making performance over time
While too few of the pesticide applicator group in 2009 returned for
testing in 2010 to provide the same level of analysis that could shed
light on the possibility of a year-to-year decline in performance, it is
possible to illustrate applicator team performance relative to the
Fig. 7. Association of AChE inhibition compared to baseline (Session 1) with
time to complete Trail Making A or B.
W.K. Anger, et al. ?????????????????????????????????
???
controls who were only tested in 2010 by combining the applicator
team job titles (viz., applicators, technicians, engineers) into a single
group. Trail Making Test performance is described for the 44 subjects (4
applicators, 19 technicians, 21 engineers) who completed both tests A
and B during Years 1 and 2, together with 150 controls who took both A
and B for the ﬁrst time in Year 2 (2010). The mean time to complete the
Trail Making Test was computed according to control (n=150) and
pesticide application teams (n=44) (Fig. 8). Session 1 is included only
for controls because they, unlike the application team members, re-
ceived the correct testing instructions in Session 1. Though controls
were tested only in 2010, the impact of learning the skill of Trail
Making Test performance necessitates that their performance in 2010
be compared to agriculture workers from 2009 as both groups were
experiencing testing for the ﬁrst time. Fig. 8 shows the improvement
over time with succeeding administrations of the test, reﬂecting
learning and increasing familiarity with test performance. This is
Table 3
Estimated change in mean performance (in s) for Trail Making A according to job title, adjusted for various demographic and exposure variables. All models use
robust standard errors to account for non-constant variance; comparisons between models show signiﬁcance of those additional terms used to adjust performance
beyond job title. and age.
Model 1 (M1) Model 2 (M2) Model 3 (M3)
Variable Est. SE p Est. SE p Est. SE p
Occupation
Eng. – Appl. −19.7 10.2 0.06 −18.9 8.5 0.03 −18.2 8.6 0.04
Tech. – Appl. −16.3 8.2 0.05 −15.3 8.8 0.09 −15.3 8.5 0.08
Eng. – Tech. −3.5 7.2 0.64 −3.6 4.5 0.43 −2.9 5 0.56
Age
per 10 yrs 10.1 3.6 0.01 8.6 4.0 0.04 8.6 4.1 0.04
Education
per 1 yr −0.2 2.4 0.92 −0.5 2.4 0.84
Work for MOA
per 1 yr 0.4 0.2 0.05 0.4 0.2 0.05
GMa TCPy
per 15 ng/mg creat. −0.6 0.5 0.21
Relativeb AChE
per 10 percentage point decrease 0.6 4.4 0.88
Relativeb BuChE
per 10 percentage point decrease 1.6 1.6 0.34
[Bayesian Information 1252.7 1261.2 1274.3
Criterion (lower is better)
Model Comparisons
M2 vs M1 (simultaneous test of education, work) F(2, 118)= 2.03, p= 0.14
M3 vs M2 (simultaneous test of all 3 exposures) F(3, 115)= 0.60, p= 0.62
M3 vs M1 (simultaneous test of all eﬀects other than age, occupation) F(5, 115)= 1.12, p= 0.35
a Geometric mean from Session 2 & 3.
b Geometric mean activity from Session 2 & 3, divided by activity at Session 1.
Table 4
Estimated change in mean performance (in s) for Trail Making B according to job title, adjusted for various demographic and exposure variables. All models use
robust standard errors to account for non-constant variance; comparisons between models show signiﬁcance of those additional terms used to adjust performance
beyond occupation and age.
Model 1 (M1) Model 2 (M2) Model 3 (M3)
Variable Est. SE p Est. SE p Est. SE p
Occupation
Eng. – Appl. −32.6 14.2 0.02 −23.3 14.8 0.12 −19.8 17.2 0.25
Tech. – Appl. −7.7 12.4 0.54 −4.3 12.3 0.72 −2.0 14.3 0.89
Eng. – Tech. −24.9 8.8 0.01 −19.0 9.7 0.05 −17.8 10.0 0.08
Age
per 10 yrs 12.2 5.8 0.04 11.9 6.3 0.06 11.6 6.6 0.08
Education
per 1 yr −2.2 1.7 0.22 −2.5 1.8 0.17
Work for MOA
per 1 yr −0.3 0.5 0.54 −0.3 0.5 0.52
GMa TCPy
per 15 ng/mg creat. −0.3 2.2 0.90
Relativeb AChE
per 10 percentage point decrease −0.6 4.3 0.90
Relativeb BuChE
per 10 percentage point decrease 1.8 5.1 0.73
BIC (lower is better) 1288.4 1295.5 1309.3
Model Comparisons
M2 vs M1 (simultaneous test of education, work) F(2, 118)= 1.06, p= 0.35
M3 vs M2 (simultaneous test all 3 exposures) F(3, 115)= 0.05, p= 0.98
M3 vs M1 (simultaneous test of all eﬀects other than age, occup.) F(5, 115)= 0.62, p= 0.68
a Geometric mean from Session 2 & 3.
b Geometric mean activity from Session 2 & 3, divided by activity at Session 1.
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consistent with the neuropsychological literature (Duﬀ et al., 2012;
Fernandez-Ballesteros et al., 2005; Nguyen et al., 2015) and with test
results from adolescent Egyptian pesticide applicators who worked in
the cotton ﬁelds, and were tested repeatedly (Ismail et al., 2017b). The
Egyptian Trail Making Test scores are considerably higher (slower) than
those collected on community members in North America of roughly
the same age and educational background (as reported by Tombaugh,
2004), though cultural diﬀerences may make comparisons to results
from other geographical/cultural areas moot (Stanczak et al., 2001).
Fig. 8 also shows that the applicator team members could achieve or
exceed the same level of performance as controls, it just took longer to
reach that level than was the case for the controls. Of course, if the
controls were given an equal amount of practice their performance may
have been far better.
4. Discussion
Previous research has demonstrated that Egyptian pesticide appli-
cator team members exposed to CPF had impaired performance on Trail
Making Tests A and B compared to controls (T. M. Farahat et al., 2003).
Several other studies of occupational OP pesticide exposure have re-
ported the same outcome on the Trail Making Test as well as on other
behavioral tests (Blanc-Lapierre et al., 2013; Cole et al., 1997; Korsak
and Sato, 1977; Mackenzie Ross et al., 2010; Richter et al., 1992;
Rosenstock et al., 1991; Wesseling et al., 2002), whereas a smaller
number of studies have not observed a similar impact of OP exposures
(Fiedler et al., 1997; Roldan-Tapia et al., 2006). The results of the
present study are consistent with those studies that report an associa-
tion between occupational OP exposures and deﬁcits in behavioral test
performance, and signiﬁcantly extend them by demonstrating a re-
lationship between behavioral test deﬁcits and two job titles with dif-
fering exposure levels plus control, which suggests a dose-response
relationship. Pesticide applicators had signiﬁcantly higher exposure
levels than technicians or engineers based on urinary TCPy measures,
and controls had signiﬁcantly lower exposure levels than any of the
occupational groups. Performance on the Trail Making Test A and B was
poorest for the applicators, better for the technicians and engineers, and
best for the controls in four testing sessions. The group diﬀerences in
urinary TCPy measures did not persist after applications stopped, but
the group diﬀerences on Trail Making Test performance observed
during the time of applications were still evident up to a month after the
applications had ended. These continued deﬁcits after exposures ended
are consistent with prior research (Rohlman et al., 2016). Urinary TCPy
and blood cholinesterase measures taken at the time of testing did not
correlate with the deﬁcits seen on the Trail Making Test in our study;
although some research has found correlations between test perfor-
mance and these biomarkers (e.g., Ismail et al., 2017b).
4.1. Urinary TCPy associated with job titles
Applicators had higher GM urinary TCPy concentrations than either
engineers or technicians at Sessions 1–3, while the urinary TCPy con-
centrations of Engineers and Technicians did not diﬀer signiﬁcantly
(Fig. 3). This establishes that there are two diﬀerent levels of exposure
associated with the job titles and thus establishes a basis for deﬁning a
dose response for performance diﬀerences in participants in those job
titles. Data from University employees not working in agriculture sug-
gest that “control” exposure levels are at the midpoint of Session 1 le-
vels in the engineers and technicians and below that of the applicators.
4.2. Blood cholinesterase measures
AChE activity did not diﬀer signiﬁcantly among job classiﬁcations
over the time from pre-application (Session 1) to during application
(Session 3) to post-application (Sessions 4 and 5), but all three job titles
showed the same decrease of ∼2.7 % for successive sessions (e.g., 2.7 %
reduction from Session 1 to Session 3; 2.7 % reduction from Session 3 to
Session 5), and this decrease was signiﬁcant. The magnitude of these
changes are lower than those seen in the same population in 2008, the
year prior to the year these data were collected; applications were be-
lieved to be more extensive in 2008 based on anecdotal reports of
participants (Singleton et al., 2015).
BuChE activity decreased more for applicators than for the other
two occupations when comparing Session 3 (during exposure) against
Session 1 (pre-exposure); technicians and engineers had the same
BuChE proﬁles over time, although these two job classiﬁcations also
showed a decrease compared to the pre-application time (Session 1).
BuChE levels were uniformly lower in all job type groups than in MOA
controls sampled in 2010 over Sessions 1, 2, 3. The lower conﬁdence
limit for these controls was higher than the upper limit of the levels of
the application job types indicating that BuChE activity did reﬂect ex-
posures from recent applications (Fig. 4, B).
Fig. 8. Average performance on Trail Making A (left) and B (right) over repeat sessions in years 2009 and 2010 for agricultural workers (black line, ﬁlled squares).
MOA controls (gray line, open circle) are shown for comparison. The gray shaded columns identiﬁy the period during which pesticides were being applied.
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Our data are consistent with the Garabrant et al. (2009) report
demonstrating that plasma BuChE activity, which constitutes 99 % of
human plasma B-esterase activity (van Gemert et al., 2001), is a mea-
sure of exposure that can be inhibited at exposure levels below those
required to inhibit red blood cell AChE.
4.3. Diﬀerences in trail making performance by job title
For both Trail Making A and B, the changes in performance ob-
served over time were similar across all job titles (viz., no signiﬁcant
job x time interaction) as demonstrated by parallel performance proﬁles
over time (Fig. 5). The ordering was always the same: Applicators were
slowest, followed by technicians, with engineers being fastest among
those working on the pesticide application teams. The MOA controls
were always fastest, compared to the pesticide application team mem-
bers, and on the more challenging Trail Making part B, they performed
signiﬁcantly faster than all other groups at all time points. There also
were diﬀerences in urinary TCPy measures between the job titles
(Table 3, 4.1). Even after adjusting for age, there were Trail Making
Test diﬀerences between job categories, and those diﬀerences remained
constant across all testing sessions (as indicated by parallel perfor-
mance proﬁles) both during and after CPF exposures in the ﬁelds. Age,
adjusted for in the analyses as noted above, was a signiﬁcant factor and
was associated with a 13 s increase in completion time for each 10 years
of increasing age on Trail Making B. After accounting for occupation
and age, years of education and years of work experience were not
signiﬁcant predictors of performance (as noted in section 3.4).
These results establish that occupational exposures to CPF were
associated with dose-dependent deﬁcits in human performance. This is
established by the diﬀerences between the applicators (whose exposure
was the highest but whose Trail Making performance was the lowest),
the engineers/technicians (whose exposure was lower than that of the
applicators and higher than controls, but whose Trail Making perfor-
mance was better than the applicators and worse than the controls) and
the controls (with the lowest exposures and the best Trail Making
performance) as seen in Figs. 3, 4, and 6. This was true both during CPF
exposures and after exposures had ended.
This has been a point of contention for some authors who doubted
the evidence that exposures to CPF aﬀect behavioral test performance
because the studies did not have data from exposures over time pri-
marily due to CPF (i.e., there were many pesticide exposures involved)
or there was only one exposed group, or both, as noted by Meyer-Baron
et al. (2015). In the present study, we report one group with higher and
two groups with lower exposure levels, plus controls with much lower
exposure levels; the controls’ exposures may have been due to home
exposures as CPF is widely available commercially, and was reportedly
used for insect control in homes (F. M. Farahat et al., 2011; Lein et al.,
2012).
4.4. Results from studies in Egypt: relationships between CPF exposures and
test performance
There were no relationships between classic biomarkers of OP ex-
posure and Trail Making performance in the present study, but some of
the other studies of Egyptian adolescent pesticide applicator teams have
reported such relationships. The present study did see an association
between AChE activity and improved performance (faster times to
complete) on Trail Making B (p= 0.03), but a marginal association was
also seen with slower performance on Trail Making A (p= 0.07). Since
the changes were in the opposite direction, the associations do not
create a compelling case. Further, there was no relationship of the other
widely-used measures of recent OP exposures, urinary TCPy levels or
blood BuChE activity (Crane et al., 2013; Singleton et al., 2015), with
Trail Making performance. T. M. Farahat et al. (2003) also recruited
adults but relationships between biomarker data and Trail Making
performance (the test was administered individually in a quiet room)
was not correlated with AChE. This is summarized in Table 5.
The remaining studies recruited adolescents. Abdel Rasoul et al.
(2008)’s adolescent applicators had signiﬁcantly lower AChE activity
(240 IU/L) than the children from the same village who did not work in
the cotton ﬁelds who served as controls (283 IU/L). The participants
were divided into older (16–18 years) and younger (9–15 years) groups,
and applicators had signiﬁcant deﬁcits in Trail Making A and B per-
formance compared to controls in both age groups. There were sig-
niﬁcant correlations between Trail Making B performance and AChE
activity, days worked during the current season, and years worked as an
applicator, all diﬀering from the current study (Table 5).
Ismail et al. (2017b) recruited adolescent applicators and controls
from the same community who had not worked in the cotton ﬁelds. The
groups were combined for regression analyses of biomarkers and TMT
performance. Data were drawn from four sessions, two during CPF
application periods and two prior to application periods, over two
years. There was a signiﬁcant relationship between higher urinary TCPy
concentrations and performance deﬁcits in Trail Making B, and AChE
activity was negatively correlated with Trail Making A performance
(Table 5).
Ismail et al. (2017a) analyzed data from adolescent pesticide ap-
plicators and non-applicators from two years (2005 and 2009). Group
diﬀerences on Trail Making were not reported, but mixed model cor-
relation analyses revealed correlations between Trail Making perfor-
mance and urinary TCPy levels (B only) and blood AChE activity (A
only), but not blood BuChE activity (Table 5). Thus, studies of adoles-
cents have found correlations between Trail Making test performance
and the standard biomarkers of recent exposure. One study of adult
agricultural workers with diverse undocumented exposures in the US
also reported correlations between AChE and several behavioral test
measures, though none was Trail Making (Rothlein et al., 2006).
Table 5
Evidence of Adverse Eﬀects on the Trail Making Test in Studies of Chlorpyrifos-Exposed Adult and Adolescent Samples and Correlations of Trail Making Results with
Biomarkers.
Study Age of sample
(y)
Exposure of C v. E Deﬁcit on A Deﬁcit on B Correl. with
TCPy
Correl. with
AChE
Correl. with
BuChE
Present 48-54 TCPy: 5.5–6.3 (C) v. 12 (T&E) v. 21 μg/g creat. (A)
BuChE: 0.86 (A) v. 0.94 (T&E) U/ml *
Yes Yes No No No
Farahat et al. (2003) 42 AChE: 108 v. 87 U/ml Yes Yes • No •
Abdel Rasoul et al.
(2008)
9-18 AChE: 283 v. 240 IU/L Yes Yes • Yes •
Rohlman et al. (2016) 16-17 TCPy:<1559 (C) v.> 1.6 ng/g creat. Yes Yes • • •
Ismail et al. (2017a) 15 No comparisons • • Yes (B) Yes (A) No
Ismail et al. (2017b) 15 33-42 % of applicators had BuChE depression vs.
5–13 % of non-applicators
No Yes • • Yes
Notes: C= control; T= technician; E= engineer; A= applicator. “•” indicates tests were not reported in the article. Data rounded to nearest whole number to
facilitate visual inspection of the results. * No diﬀerence in AChE between applicators and technicians or engineers. 2017a= JTEH article. 2017b= PLOSone article.
Creat. = creatinine.
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Since the Ismail et al. (2017b) study tested adolescents from the
same population as our adult participants (cotton ﬁeld applicators/
teams working for the Ministry of Agriculture in the Nile Delta), though
using a slightly diﬀerent analytic approach, we took a more focused
look at the association between Trail Making A and B performance
(Sessions 2–5) and log(TCPy) concentration from Sessions 2-5. Fol-
lowing the Ismail et al. (2017b) methodology, we used a mixed-eﬀect
model for the response (Trail Making A and B latency; no transforma-
tion) with testing session as a factor and contemporaneous log(TCPy) as
predictors. Ismail et al. (2017b) made further adjustment for education
rather than age of individual, so we ran models with both age and
education even though years of education appeared to be non-sig-
niﬁcant in the Ismail et al. reporting of Trail Making A and B perfor-
mance (the authors reported that they only include one of these vari-
ables in the analysis because age and education were highly correlated).
Our models for Trail Making A and B each used 138 participants (30
Applicators, 51 Engineers, 57 technicians); data from one technician is
lost if education rather than age is used for the analysis.
Considering Trail Making B adjusted for age, the log(TCPy) eﬀect
was -0.85 (95 % CI: -7.96 to 6.26; p= 0.815) and was -1.32 (95 % CI:-
8.46 to 5.82; p= 0.717) when adjusted instead for education in our
adult sample (results for A were similarly non-signiﬁcant). Thus, using
these same models (mixed models vs GEE; using transformed TCPy as a
predictor instead of occupation) we still reach the conclusion that there
is no association between TCPy and Trail Making B (or A) performance.
The eﬀect for Trail Making B reported by Ismail et al. (2017b) translates
to ∼2.1 (95 % CI: 0.7–3.4) s worse performance for each doubling in
TCPy concentration. To relate these concentrations to the present study,
a cohort of adolescents having geometric mean (GM) concentration of
30 μg TCPy/g creatinine would be about 2.1 s slower than a cohort with
GM concentration of 15 μg TCPy/g creatinine (the diﬀerence between
the approximate GM concentration of TCPy in our applicator group
[30] and that of our controls [15] per Fig. 3). This same performance
reduction would occur when comparing any two cohorts where average
Table 6
The Nine Bradford-Hill (Hill, 1965) Criteria and the Evidence that Supports or Meets Each Criterion.
Criterion Supporting Evidence
1) Strength (e.g., eﬀect size) The eﬀect size (d) of the score diﬀerences between exposed and controls in the T. M. Farahat et al.
(2003) study was 0.55 for Trail Making A and 0.61 for B; both are moderate eﬀect sizes per Cohen
(1992). In the present study of a workforce from the same population, applicators completed the Trail
Making A task an average of 19.7 (95% CI: 3.8 - 35.6; p= 0.015; d ∼ 0.38) s slower than engineers
and 12.7 (95% CI: 1.1 - 24.4; p= 0.032; d ∼ 0.24) s slower than technicians. For Trail Making B,
applicators were 30 (95% CI: 6.5 - 53; p= 0.012; d ∼ 0.46) s slower than engineers and 3.2 s slower
than technicians (p= 0.747; d ∼ 0.05); technicians were 26 (95% CI: 9 - 44; p= 0.003; d ∼ 0.41) s
slower than engineers at each of the testing sessions. The eﬀect sizes are model-based rather than
derived from the mean and standard deviation as developed by (Cohen, 1992).
2) Consistency (e.g., reproducibility from multiple studies) Demonstrated by the Munoz-Quezada et al. (2016) review identifying 8 studies that documented
poorer exposed group performance on the Trail Making Test compared to control groups. The present
study adds a ninth that replicates and extends one prior ﬁnding in the same population of pesticide
applicators (T. M. Farahat et al., 2003).
3) Speciﬁcity (e.g., there is a speciﬁc population at a speciﬁc site with no
other likely explanation)
Demonstrated by two studies (the present study and T. M. Farahat et al., 2003) with the same result
in diﬀerent samples from the same population primarily exposed occupationally to only one
neurotoxic pesticide, CPF. There is limited evidence that exposure to pyrethroids, to which this
population is also exposed, reduces performance on some cognitive tests (Hansen et al., 2017) though
not those with a motor component as seen in the present studies.
4) Temporality (e.g., does the exposure precede the eﬀect) Demonstrated for chronic exposures by the diﬀerences between the controls and exposed and for
recent exposures by Rohlman et al. (2016) in adolescent pesticide applicators in this same population
that had better performance on the Trail Making test before and after applications by these young
applicators (e.g., as a well-paying summer job).
5) Biological gradient (e.g., greater exposure should generally lead to
greater incidence of the eﬀect, or dose response)
Dose-related eﬀect based job title demonstrated for the ﬁrst time in multiple levels by the present
study, as applicators, who had the greatest CPF exposure, had the poorest performance, while
engineers/technicians who had CPF exposures lower than applicators but higher than controls, had
intermediate performance and controls who had the lowest CPF exposures had the best performance.
This is supported by the Meyer-Baron et al. (2015) meta-analysis of 22 studies relating duration of OP
pesticide exposure in years (history/range of OP pesticides not documented) to performance deﬁcits
on a range of behavioral tests (including Trail Making).
6) Plausibility (e.g., a plausible mechanism of cause and eﬀect) While ACHE inhibition is known to mediate the acute neurotoxic eﬀects of OPs, considerable
evidence in the human and animal literature point to non-cholinergic mechanisms of neurotoxicity
following chronic exposures (Voorhees et al., 2016). How chronic OP exposures cause behavioral
deﬁcits remains an area of active research, but there is evidence implicating neuroinﬂammation and
oxidative stress: chronic OP exposures has been shown to trigger neuroinﬂammation and oxidative
stress (Guignet and Lein, 2019; Naughton and Terry, 2018) and both of these neuropathological
responses have been linked to behavioral deﬁcits in humans and animals. Thus there is a plausible
mechanism to link chronic OP exposures to behavioral deﬁcits.
7) Coherence (viz., does not conﬂict with known facts of biological eﬀects
of OP chemicals)
As indicated under criterion 6 above, there is signiﬁcant evidence in the experimental literature that
under conditions of well-controlled exposures, OPs, including CPF, cause behavioral deﬁcits via non-
cholinergic mechanisms (Voorhees et al., 2016). Thus, the human data are coherent with the known
facts of biological eﬀects of OP chemicals.
8) Experiment (viz., agrees with experimental studies) Studies in a rat model with exposures based on those reported for Egyptian pesticide workers in this
study demonstrated behavioral deﬁcits in a cued learning test in two contexts or settings associated
with CPF exposures (as related to attention also measured by the Trail Making Test) that appeared
only after repeated exposures (viz., 15 exposures but not after 5 or 10 exposures). The series of
studies also presents evidence that AChE is a poor biomarker of the eﬀects of repeated exposures
(Lattal et al., 2010). Experimental studies suggest that CPF-induced behavioral deﬁcits appear to be
causally related to oxidative stress (Lein, unpublished data)
9) Analogy (e.g., similar evidence from related compounds or conditions) The Munoz-Quezada et al. (2016) systematic review of studies of chronic OP exposure in adults
revealed that 24 of 35 studies found adverse neurobehavioral eﬀects, including 8 that used the Trail
Making Test. There is independent evidence in children who apply the same pesticide in Egypt of
adverse behavioral eﬀects of CPF (Rohlman et al., 2016).
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concentration is separated 2-fold.
Overall, the present study identiﬁes a dose-related eﬀect based on
job title associated with CPF exposure measures (of the groups as noted
in 4.2 and 4.3) and Trail Making performance. However, a dose re-
sponse relationship cannot be based on the classic measures of recent
CPF exposure (viz., TCPy and AChE or BuChE; Singleton et al., 2015;
Crane et al., 2013) and Trail Making performance in adults, though
there are correlations between Trail Making performance and bio-
markers of recent CPF exposure in adolescents, which we cannot ex-
plain. These data suggest that the classic CPF exposure measures that
reﬂect recent exposures are not predictive of persistent eﬀects detected
at times well beyond the exposure period in adults, although they may
be used to identify those individuals who will, after an extended period
of such exposures, be at risk of reduced cognitive function. A similar
conclusion was reached by Meyer-Baron et al. (2015).
The reason for the disconnect between the observation that deﬁcits
in Trail Making performance are correlated with job titles that diﬀer in
chlorpyrifos exposure as determined by urinary TCPy values, and the
lack of signiﬁcant correlation between individual urinary TCPy levels
and behavioral outcomes is unknown. Perhaps it is due to the fact that
urinary TCPy levels increase rapidly initially and then remain fairly
steady throughout the exposure period while behavioral deﬁcits man-
ifest only after chronic exposures and remain after urinary TCPy levels
return to baseline. In other words, there is a temporal disconnect be-
tween these two measures. It may also indicate that CPF exposures
diﬀerentially aﬀect peripheral systemic processes (e.g., hepatic meta-
bolism of CPF to TCPy) and central nervous system processes. The lack
of correlation between AChE and BChE activity and behavior supports
the hypothesis that these two outcomes are mechanistically unrelated
(a conclusion also oﬀered by Rohlman et al., 2011). Terry (2012) and
Zurlinden and Reisfeld (2018) propose a similar hypothesis, the latter
asserting that cognitive outcomes following chlorpyrifos exposure “may
be more sensitive markers of adverse health eﬀects than AChE inhibi-
tion” page 047009-2.
4.5. Causal relationship between CPF exposure and trail making
performance deﬁcits
The identiﬁcation of a dose-response relationship for CPF eﬀects on
the Trail Making Test is an important addition to the evaluation of
whether there is a causal relationship between CPF exposures and Trail
Making Test performance. With the addition of these new data, CPF
meets all of the 9 Bradford Hill criteria for concluding that an exposure
has a causative eﬀect on the performance measure based on evidence
from epidemiologic studies (Table 6).
Thus, all 9 of the Bradford-Hill criteria are met convincingly by
experimental evidence to support a causative eﬀect of CPF exposures on
neurobehavioral deﬁcits, speciﬁcally on the Trail Making Test. This
establishes CPF as a neurotoxic substance, underscoring the need to
implement exposure controls to prevent chronic exposures that can lead
to neurotoxicity.
4.6. Limitations
We did not attempt to measure exposures to pyrethroids, the in-
secticide(s) used between the two longer periods of chlorpyrifos ap-
plications. As reported in a recent systematic review of pyrethroid
neurotoxicity (Chrustek et al., 2018), oral administration in animals led
to motor dysfunction and tremors in one experimental study, and in
motor coordination and learning deﬁcits in rats in another study, but
there is limited evidence from adult human case studies that dermal
exposures to pyrethroids may be associated with neurotoxic damage
(viz. tremors). Thus, while we cannot rule out the possibility that
pyrethyroid exposure contributes to the lack of association between
biomarkers of CPF exposure and behavioral eﬀects noted in this po-
pulation, it is diﬃcult to determine how much of a confounding factor
this is given that the evidence for their occupational neurotoxicity in
humans is quite limited.
The Trail Making Test was administered in a relatively quiet small
room in 2009 but in a larger room with other activities going on in
2010, which provided a less optimal setting for the test and led us to
avoid behavioral test comparisons between the years. Often there were
several people in the room completing surveys waiting for their turn for
the test, so conversation and interactions may have sometimes dis-
tracted those taking the test. Controls were tested in a room with other
testing activities which would be expected to be more distracting cir-
cumstances. While not ideal testing circumstances, it was typical of the
culture to have frequent interactions with others, and individual rooms
were not available for testing the large numbers recruited for the study.
Our sample of applicators was drawn from three MOA stations and
may not have been representative of overall exposures in Egypt or in
other countries.
While the pesticide applicator teams we studied did not apply pes-
ticides to any other crop in their occupation, they did in some cases
state that they took on side jobs involving episodic pesticide application
such as for farmers who grew crops other than cotton (Ismail et al.,
2012; Lein et al., 2012).
5. Conclusion
In sum, there is ample evidence that Trail Making performance
deﬁcits are associated with job title, and job title is associated with
diﬀerent levels of chlorpyrifos exposure. The applicators who had the
highest chlorpyrifos exposures had the greatest performance deﬁcit,
while the engineers who had the lowest exposures had the least deﬁcit.
Controls who did not work in or next to the ﬁelds, and had the lowest
CPF exposures, had the best Trail Making performance. This is the ﬁrst
evidence of a dose-related eﬀect for behavioral deﬁcits associated with
occupational exposures to CPF based on job title, establishing it as a
neurotoxic substance in adult humans.
Because Trail Making performance was not associated with the
classic biomarkers of recent chlorpyrifos exposure in the adults we
studied, and not consistently associated with those biomarkers in other
studies of children from this population (Table 5), we conclude that
they are not mechanistically relevant biomarkers of eﬀect caused by
chronic or repeated, long-term exposure to chlorpyrifos in adults. We
believe it is the long-term exposures that produced behavioral changes,
especially since they were not correlated with biomarkers of recent
exposure, and because the group diﬀerences persisted when exposures
ended. The lack of correlation of behavioral performance deﬁcits with
the acute exposure biomarkers should not be considered evidence that
the eﬀects are specious or lacking in rigor as some have suggested (as
documented by Meyer-Baron et al., 2015).
The present data suggest that the OP chlorpyrifos joins 6 other
chemicals with demonstrated neurotoxic eﬀects in humans by pro-
viding a key Bradford-Hill criterion indicative of strong evidence of a
cause-eﬀect relationship: Lead (Lanphear et al., 2005), methylmercury
(Debes et al., 2006), manganese (Bowler et al., 2007; Claus Henn et al.,
2010), polychlorinated biphenyls (PCBs) (Lin et al., 2008; Stewart
et al., 2008), arsenic (Wasserman et al., 2004) and styrene (Benignus
et al., 2005). While the adverse eﬀects of lead, methylmercury, man-
ganese and PCB are directly and proportionately associated with bio-
marker concentrations (blood lead at time of testing, cord blood mer-
cury at birth, blood manganese at time of testing, PCBs in placental
tissue at birth, respectively), arsenic and styrene are associated with a
relevant exposure marker (arsenic concentrations in well water con-
sumed and airborne exposure levels in the chamber at the time of
testing, respectively). Thus, this association of Trail Making perfor-
mance with adults’ TCPy associated with job type is more direct and
thus convincing than is the case with arsenic and styrene but slightly
less so than that for lead, methylmercury, manganese and PCBs.
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